Jan Sobczak
6PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 26, 2024
Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874.Dominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger
|Aug 29, 2024
Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes.Dominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger
|Jun 27, 2024
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response.Jan M Sobczak, Irena Barkovska, Ina Balke
|Oct 10, 2023
Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergy.Pascal S Krenger, Romano Josi, Jan Sobczak
|Oct 04, 2023
BALB/c and C3H mice are both suitable as peanut allergy models.Pascal S Krenger, Jan Sobczak, Marta Paolucci
|Mar 08, 2023
The next generation virus-like particle platform for the treatment of peanut allergy.Jan M Sobczak, Pascal S Krenger, Federico Storni
Pageof 1
Frequent Collaborators
6 joint publications
Martin F Bachmann
5 joint publications
Monique Vogel
3 joint publications
Ina Balke
2 joint publications
Matthew D Heath
2 joint publications
Matthias F Kramer
2 joint publications
Pascal S Krenger
2 joint publications
Dominik A Rothen
2 joint publications
Sudip Kumar Dutta
2 joint publications
Albert D M E Osterhaus
2 joint publications
Mona O Mohsen
